文献速递烧伤

氧雄龙治疗成年烧伤患者转氨酶升高风险因素分析

Risk Factors Associated with the Development of Transaminitis in Oxandrolone-Treated Adult Burn Patients.
PubMed 文献 · J Burn Care Res · 2019-01-01

本研究为多中心回顾性风险因素分析,纳入309例使用氧雄龙的成年烧伤患者,41.4%在用药13天后出现转氨酶升高。多因素分析显示年轻、使用静脉升压药或胺碘酮是独立预测因素,转氨酶升高与住院时间或死亡率无显著关联。

要点

  • 氧雄龙治疗成年烧伤患者转氨酶升高发生率为41.4%。
  • 年轻、静脉升压药及胺碘酮使用是独立风险因素。
  • 转氨酶升高未显著增加住院时间或死亡率。

核心结论

  • 年轻及合并使用胺碘酮或升压药的患者发生氧雄龙诱导转氨酶升高的风险最高,应密切监测。

研究设计与样本

  • 多中心回顾性风险因素分析,纳入309例使用氧雄龙的成年烧伤患者,比较转氨酶升高组与未升高组。

主要发现

  • 128例(41.4%)出现转氨酶升高,发生在用药后13天(IQR 8-23)。
  • 多因素分析显示年龄(每增加5岁OR 0.91;95%CI 0.84-0.99)、静脉升压药(OR 1.85;95%CI 1.05-3.27)和胺碘酮(OR 2.51;95%CI 1.09-5.77)是独立预测因素。
  • 调整年龄和TBSA%后,转氨酶升高与住院时间或死亡率无显著关联。

关键数值与推荐

  • 转氨酶升高定义为AST或ALT >100 mg/dL。

临床怎么用

  • 对年轻、使用升压药或胺碘酮的烧伤患者,使用氧雄龙时应加强肝功能监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oxandrolone has proven benefits in thermal burn injury and has become a standard of care. Transaminitis is the most frequent side effect of oxandrolone use, although no risk factors have been identified that increase the risk of transaminitis. The objective was to evaluate the frequency of transaminitis while on oxandrolone and to identify risk factors leading to an increased risk of transaminitis in adult burn patients. This multicenter retrospective risk factor analysis compared two patient groups with and without occurrence of transaminitis, which was detected by an aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >100 mg/dL. Secondary outcomes included percentage increase from baseline for AST/ALT, length of stay, and mortality. After univariable analysis, a multivariable logistic regression analysis was performed to detect possible risk factors leading to transaminitis. A total of 309 patients were included, with transaminitis occurring in 128 patients (41.4%) after 13 (interquartile range [IQR] 8-23) days on oxandrolone. After multivariable analysis, age (odds ratio [OR] 0.91; 95% confidence interval [CI] 0.84-0.99 for a 5-year increase in age), intravenous vasopressor use (OR 1.85; 95% CI 1.05-3.27), and amiodarone use (OR 2.51; 95% CI 1.09-5.77) were independent predictors of transaminitis, controlling for TBSA%. Transaminitis was not significantly associated with length of stay or mortality after adjusting for age and TBSA%. We conclude that patients who are younger and have concurrent amiodarone or vasopressor use have the highest risk of developing oxandrolone induced transaminitis and should be monitored closely.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Kiracofe B, Zavala S, Gayed RM, et al. Risk Factors Associated with the Development of Transaminitis in Oxandrolone-Treated Adult Burn Patients. J Burn Care Res. 2019. PMID: 31220261. doi:10.1093/jbcr/irz041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。